Investor Presentaiton

Progress on Capacity expansion Reactor Volumes Over 4x in last 7 years Reactor Capacity (KL) 25 25 220 1,870 4,638 Drug Product Capacity Expanded 5x in last 7 years 7,480 Oral Solids (billion) FY06-11 FY11-16 FY16-21 FY23 2 5 Fermentation Capacity Expanded 18x since acquisition 190 10 Fermentation (KL) FY11-16 FY16-21 FY23 10 FY21^ FY23 +500 KL New capacity under construction for FY24 delivery Well positioned for success through leading commercial offering, supported by ongoing growth Investment ^ Since Acquisition of Laurus Bio (Feb 2021) Laurus Q2 & H1 FY 2024 Investor Presentation | October 20, 2023 LAURUS Labs Knowledge. Innovation. Excellence

View entire presentation